Presence of Autoantibody Against Two Placental Proteins, Peroxiredoxin 3 and Peroxiredoxin 4, in Sera of Recurrent Pregnancy Loss Patients

American Journal of Reproductive Immunology

Volumn 69, Issue 3, 2013, Pages 248-255

  Gharesi Fard, Behrouz ^a,b   Jafarzadeh, Leila ^a   Ghaderi shabankareh, Farzaneh ^a   Zolghadri, Jaleh ^a,b   Kamali Sarvestani, Eskandar ^a,c  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Peroxiredoxin 3; Peroxiredoxin 4; Placenta; Proteomics; Recurrent pregnancy loss

Indexed keywords

AUTOANTIBODY; MATERNAL ANTIBODY; MONOCLONAL ANTIBODY; PEROXIREDOXIN 3; PEROXIREDOXIN 4; POLYVINYLIDENE FLUORIDE;

ABORTION; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EXTRACTION; FEMALE; HUMAN; HUMAN TISSUE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN TARGETING; RECURRENT PREGNANCY LOSS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ABORTION, HABITUAL; ADULT; AUTOANTIBODIES; AUTOIMMUNE DISEASES; FEMALE; HUMANS; PEROXIREDOXIN III; PEROXIREDOXINS; PREGNANCY; PREGNANCY PROTEINS; RISK; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84873521733     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/aji.12042     Document Type: Article

References (36)

1. Branch DW, Gibson M, Silver RM: Clinical practice. Recurrent miscarriage. N Engl J Med 2010; 363:1740-1747.
2. Ford HB, Schust DJ: Recurrent pregnancy loss: etiology, diagnosis, and therapy. Rev Obstet Gynecol 2009; 2:76-83.
3. Pandey MK, Rani R, Agrawal S: An update in recurrent spontaneous abortion. Arch Gynecol Obstet 2005; 272:95-108.
4. Duckitt K, Qureshi A: Recurrent miscarriage. Clin Evid (Online) 2011; 2011:pii:1409.
5. Beaman KD, Ntrivalas E, Mallers TM, Jaiswal MK, Kwak-Kim J, Gilman-Sachs A: Immune etiology of recurrent pregnancy loss and its diagnosis. Am J Reprod Immunol 2012; 67:319-325.
6. Marai I, Carp H, Shai S, Shabo R, Fishman G, Shoenfeld Y: Autoantibody panel screening in recurrent miscarriages. Am J Reprod Immunol 2004; 51:235-240.
7. Staub HL, Bertolaccini ML, Khamashta MA: Anti-phosphatidylethanolamine antibody, thromboembolic events and the antiphospholipid syndrome. Autoimmun Rev 2012. doi: 10.106/j.autrev.2012.07.008.
8. John R, Hemberger M: A placenta for life. Reprod Biomed Online 2012; 25:5-11.
9. Gupta S, Agarwal A, Banerjee J, Alvarez JG: The role of oxidative stress in spontaneous abortion and recurrent pregnancy loss: a systematic review. Obstet Gynecol Surv 2007; 62:335-347; quiz 353-334.
10. Nelson KJ, Knutson ST, Soito L, Klomsiri C, Poole LB, Fetrow JS: Analysis of the peroxiredoxin family: using active-site structure and sequence information for global classification and residue analysis. Proteins 2011; 79:947-964.
11. Tavender TJ, Bulleid NJ: Peroxiredoxin IV protects cells from oxidative stress by removing H2O2 produced during disulphide formation. J Cell Sci 2010; 123:2672-2679.
12. Hoang VM, Foulk R, Clauser K, Burlingame A, Gibson BW, Fisher SJ: Functional proteomics: examining the effects of hypoxia on the cytotrophoblast protein repertoire. Biochemistry 2001; 40:4077-4086.
13. Ejima K, Nanri H, Araki M, Koji T, Shibata E, Kashimura M, Ikeda M: Expression of mitochondrial thioredoxin-dependent antioxidant protein, SP-22, in normal human and inflammatory mouse placentae. Placenta 2000; 21:847-852.
14. LaMarca B, Wallace K, Granger J: Role of angiotensin II type I receptor agonistic autoantibodies (AT1-AA) in preeclampsia. Curr Opin Pharmacol 2011; 11:175-179.
15. Noe MH, Messingham KA, Brandt DS, Andrews JI, Fairley JA: Pregnant women have increased incidence of IgE autoantibodies reactive with the skin and placental antigen BP180 (type XVII collagen). J Reprod Immunol 2010; 85:198-204.
16. Meroni PL, Borghi MO, Raschi E, Tedesco F: Pathogenesis of antiphospholipid syndrome: understanding the antibodies. Nat Rev Rheumatol 2011; 7:330-339.
17. Gharesi-Fard B, Zolghadri J, Kamali-Sarvestani E: Proteome differences of placenta between pre-eclampsia and normal pregnancy. Placenta 2010; 31:121-125.
18. Neuhoff V, Arold N, Taube D, Ehrhardt W: Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G-250 and R-250. Electrophoresis 1988; 9:255-262.
19. Franklin RD, Kutteh WH: Antiphospholipid antibodies (APA) and recurrent pregnancy loss: treating a unique APA positive population. Hum Reprod 2002; 17:2981-2985.
20. Danza A, Ruiz-Irastorza G, Khamashta M: Antiphospholipid syndrome in obstetrics. Best Pract Res Clin Obstet Gynaecol 2012; 26:65-76.
21. Blank M, Cohen J, Toder V, Shoenfeld Y: Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. PNAS 1991; 88:3069-3073.
22. Dendrinos S, Papasteriades C, Tarassi K, Christodoulakos G, Prasinos G, Creatsas G: Thyroid autoimmunity in patients with recurrent spontaneous miscarriages. Gynecol Endocrinol 2000; 14:270-274.
23. Li L, Shoji W, Oshima H, Obinata M, Fukumoto M, Kanno N: Crucial role of peroxiredoxin III in placental antioxidant defense of mice. FEBS Lett 2008; 582:2431-2434.
24. Liu AX, Jin F, Zhang WW, Zhou TH, Zhou CY, Yao WM, Qian YL, Huang HF: Proteomic analysis on the alteration of protein expression in the placental villous tissue of early pregnancy loss. Biol Reprod 2006; 75:414-420.
25. Shibata E, Nanri H, Ejima K, Araki M, Fukuda J, Yoshimura K, Toki N, Ikeda M, Kashimura M: Enhancement of mitochondrial oxidative stress and up-regulation of antioxidant protein peroxiredoxin III/SP-22 in the mitochondria of human pre-eclamptic placentae. Placenta 2003; 24:698-705.
26. Li L, Obinata M, Hori K: Role of peroxiredoxin III in the pathogenesis of pre-eclampsia as evidenced in mice. Oxid Med Cell Longev 2010; 3:71-73.
27. Chang TS, Cho CS, Park S, Yu S, Kang SW, Rhee SG: Peroxiredoxin III, a mitochondrion-specific peroxidase, regulates apoptotic signaling by mitochondria. J Biol Chem 2004; 279:41975-41984.
28. Yin G, Li C, Shan B, Wang W, Chen H, Zhong Y, Di J, Lin Q, Lin Y: Insufficient peroxiredoxin-2 expression in uterine NK cells obtained from a murine model of abortion. J Cell Biochem 2011; 112:773-781.
29. Garrido-Gomez T, Dominguez F, Lopez JA, Camafeita E, Quinonero A, Martinez-Conejero JA, Pellicer A, Conesa A, Simon C: Modeling human endometrial decidualization from the interaction between proteome and secretome. J Clin Endocrinol Metab 2011; 96:706-716.
30. Bose P, Kadyrov M, Goldin R, Hahn S, Backos M, Regan L, Huppertz B: Aberrations of early trophoblast differentiation predispose to pregnancy failure: lessons from the anti-phospholipid syndrome. Placenta 2006; 27:869-875.
31. Lash GE, Postovit LM, Matthews NE, Chung EY, Canning MT, Pross H, Adams MA, Graham CH: Oxygen as a regulator of cellular phenotypes in pregnancy and cancer. Can J Physiol Pharmacol 2002; 80:103-109.
32. Redecha P, van Rooijen N, Torry D, Girardi G: Pravastatin prevents miscarriages in mice: role of tissue factor in placental and fetal injury. Blood 2009; 113:4101-4109.
33. Karasawa R, Ozaki S, Nishioka K, Kato T: Autoantibodies to peroxiredoxin I and IV in patients with systemic autoimmune diseases. Microbiol Immunol 2005; 49:57-65.
34. Iwata Y, Ogawa F, Komura K, Muroi E, Hara T, Shimizu K, Hasegawa M, Fujimoto M, Tomita Y, Sato S: Autoantibody against peroxiredoxin I, an antioxidant enzyme, in patients with systemic sclerosis: possible association with oxidative stress. Rheumatology (Oxford) 2007; 46:790-795.
35. Karasawa R, Fujieda M, Yudoh K: Detection of specific markers: our research on the marker in patients with Kawasaki disease. Nihon Rinsho Meneki Gakkai Kaishi 2010; 33:207-213.
36. Fujieda M, Karasawa R, Takasugi H, Yamamoto M, Kataoka K, Yudoh K, Kato T, Ozaki S, Wakiguchi H: A novel anti-peroxiredoxin autoantibody in patients with Kawasaki disease. Microbiol Immunol 2012; 56:56-61.